Unidirectional and bidirectional causation between smoking and blood DNA methylation: evidence from twin-based Mendelian randomisation
Cigarette smoking is associated with numerous differentially-methylated genomic loci in multiple human tissues. These associations are often assumed to reflect the causal effects of smoking on DNA methylation (DNAm), which may underpin some of the adverse health sequelae of smoking. However, prior causal analyses with Mendelian Randomisation (MR) have found limited support for such effects. Here, we apply an integrated approach combining MR with twin causal models to examine causality between smoking and blood DNAm in the Netherlands Twin Register (N = 2577). Analyses revealed potential causal effects of current smoking on DNAm at > 500 sites in/near genes enriched for functional pathways relevant to known biological effects of smoking (e.g., hemopoiesis, cell- and neuro-development, and immune regulation). Notably, we also found evidence of reverse and bidirectional causation at several DNAm sites, suggesting that variation in DNAm at these sites may influence smoking liability. Seventeen of the loci with putative effects of DNAm on smoking showed highly specific enrichment for gene-regulatory functional elements in the brain, while the top three sites annotated to genes involved in G protein-coupled receptor signalling and innate immune response. These novel findings are partly attributable to the analyses of current smoking in twin models, rather than lifetime smoking typically examined in MR studies, as well as the increased statistical power achieved using multiallelic/polygenic scores as instrumental variables while controlling for potential horizontal pleiotropy. This study highlights the value of twin studies with genotypic and DNAm data for investigating causal relationships of DNAm with health and disease.
Authors
- Josine L. Min (ORCID: https://orcid.org/0000-0003-4456-9824)
- René Pool (ORCID: https://orcid.org/0000-0001-5579-0933)
- Gibran Hemani (ORCID: https://orcid.org/0000-0003-0920-1055)
- Dana M. Lapato (ORCID: https://orcid.org/0000-0001-8169-9754)
- Roseann E. Peterson (ORCID: https://orcid.org/0000-0001-6402-849X)
- Brad Verhulst (ORCID: https://orcid.org/0000-0001-5369-9757)
- Michael C. Neale (ORCID: https://orcid.org/0000-0003-4887-659X)
- Jouke‐Jan Hottenga (ORCID: https://orcid.org/0000-0002-5668-2368)
- HERMINE H. M. MAES (ORCID: https://orcid.org/0000-0001-7489-2214)
- Conor V. Dolan (ORCID: https://orcid.org/0000-0002-2496-8492)
- Madhurbain Singh (ORCID: https://orcid.org/0000-0002-9396-2860)
- Jenny van Dongen (ORCID: https://orcid.org/0000-0003-2063-8741)
- Eco J. C. de Geus (ORCID: https://orcid.org/0000-0001-6022-2666)
- Dorret Irene Boomsma (ORCID: https://orcid.org/0000-0002-7099-7972)
- Charles E. Breeze (ORCID: https://orcid.org/0000-0002-5294-915X)
Institutions
- National Institutes of Health (US)
- SUNY Downstate Health Sciences University (US)
- Virginia Commonwealth University (US)
- University of Bristol (GB)
- National Cancer Institute (US)
- CRUK Lung Cancer Centre of Excellence (GB)
- MRC Epidemiology Unit (GB)
- Cognitive Research (United States) (US)
- University College London (GB)
- Amsterdam University of Applied Sciences (NL)
- Vrije Universiteit Amsterdam (NL)
- Texas A&M University (US)
Publication Details
- Journal
- European Journal of Epidemiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1007/s10654-024-01187-5
- Citations
- 2
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 1.61
Funders
- University of Minnesota
- University of Bristol
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Institutes of Health
- Medical Research Council
- National Institute of Mental Health
- National Institute on Drug Abuse